| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 260,338 | 255,202 | 262,150 | 253,515 | | Cost of Revenue | 170,491 | 165,713 | 167,165 | 163,438 | | | Gross Profit | 89,847 | 89,489 | 94,985 | 90,077 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 75,290 | 75,343 | 74,528 | 82,100 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 14,557 | 14,146 | 20,457 | 7,977 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,251 | 1,816 | (420) | (489) | | Earnings Before Interest And Taxes | 15,808 | 15,962 | 20,037 | 7,488 | | Interest Expense | 5,293 | 6,005 | 5,936 | 4,359 | | Income Before Tax | 10,515 | 9,957 | 14,101 | 3,129 | | Income Tax Expense | (374) | (490) | 2,642 | 3,025 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 10,889 | 10,447 | 11,459 | 104 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (10,103) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 10,889 | 10,447 | 11,459 | (9,999) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $10,889 | $10,447 | $11,459 | ($9,999) |
|
0.53% Nasdaq 
0.08 (0.46%) 
Income Statement
